Elevated BAFF (BLyS) and APRIL in Juvenile idiopathic arthritis patients: Relation to clinical manifestations and disease activity

Quartier, 2010, Current treatments for juvenile idiopathic arthritis, Joint Bone Spine, 77, 511, 10.1016/j.jbspin.2010.09.002 Martini, 2010, Juvenile idiopathic arthritis: state of the art and future perspectives, Ann Rheum Dis, 69, 1260, 10.1136/ard.2010.133033 Townsend, 2010, B-cell targeted therapies in human autoimmune diseases: an updated perspective, Immunol Rev, 237, 264, 10.1111/j.1600-065X.2010.00945.x Mackay, 2005, The BAFF/APRIL system: an important player in systemic rheumatic diseases, Curr Dir Autoimmun, 8, 243, 10.1159/000082106 Le Pottier, 2009, New ELISA for B cell-activating factor, Clin Chem, 55, 1843, 10.1373/clinchem.2009.129940 Krivosikova, 2009, B cell activating factor, its role in autoimmunity, and targeting in autoimmune diseases, Bratisl Lek Listy, 110, 137 Becker-Merok, 2006, B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time, Lupus, 15, 570, 10.1177/0961203306071871 Gottenberg, 2009, Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort, Arthritis Res Ther, 11, R114, 10.1186/ar2773 Gross, 2000, TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease, Nature, 404, 995, 10.1038/35010115 Moura, 2011, Cytokine pattern in very early rheumatoid arthritis favours B-cell activation and survival, Rheumatology, 50, 278, 10.1093/rheumatology/keq338 Bosello, 2008, Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis, J Rheumatol, 35, 1256 Benucci, 2010, Predictive factors of response to rituximab therapy in rheumatoid arthritis: what do we know today?, Autoimmun Rev, 9, 801, 10.1016/j.autrev.2010.07.006 Hong, 2009, B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients, Arthritis Rheum, 60, 3400, 10.1002/art.24902 Petty, 2004, International League of Associations for Rheumatology. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001, J Rheumatol, 31, 390 Consolaro, 2009, Paediatric Rheumatology International Trials Organisation. Development and validation of a composite disease activity score for juvenile idiopathic arthritis, Arthritis Rheum, 61, 658, 10.1002/art.24516 Singh, 1994, Measurement of health status in children with juvenile rheumatoid arthritis, Arthritis Rheum, 37, 1761, 10.1002/art.1780371209 Bassyouni, 2011, Elevated serum levels of a proliferation-inducing ligand in patients with systemic sclerosis: Possible association with myositis?, Joint Bone Spine, 78, 56, 10.1016/j.jbspin.2010.05.004 Wouters, 2002, Different circulating lymphocyte profiles in patients with different subtypes of juvenile idiopathic arthritis, Clin Exp Rheumatol, 20, 239 Jansson, 2011, B cell depletion for autoimmune diseases in paediatric patients, Clin Rheumatol, 30, 87, 10.1007/s10067-010-1630-0 Kuek, 2006, Successful treatment of refractory polyarticular juvenile idiopathic arthritis with rituximab, Rheumatology, 45, 1448, 10.1093/rheumatology/kel301 Feito, 2009, Rituximab therapy produced rapid and sustained clinical improvement in a patient with systemic onset juvenile idiopathic arthritis refractory to TNF alpha antagonists, J Clin Rheumatol, 15, 363, 10.1097/RHU.0b013e3181ba3c6f Kasher-Meron, 2009, Successful treatment with B-cell depleting therapy for refractory systemic onset juvenile idiopathic arthritis: a case report, Rheumatology, 48, 445, 10.1093/rheumatology/ken492 Looney, 2005, B cell-targeted therapy in diseases other than rheumatoid arthritis, J Rheumatol Suppl, 73, 25 Qian, 2010, Juvenile idiopathic arthritis-associated uveitis, Curr Opin Ophthalmol, 21, 468, 10.1097/ICU.0b013e32833eab83 Parikh, 2008, Immunohistochemical study of chronic nongranulomatous anterior uveitis in juvenile idiopathic arthritis, Ophthalmology, 115, 1833, 10.1016/j.ophtha.2008.03.027 Amer, 2007, Resolution of juvenile idiopathic arthritis-associated uveitis after development of common variable immunodeficiency, Eur J Ophthalmol, 17, 666, 10.1177/112067210701700429 Tappeiner, 2007, Rituximab as a treatment option for refractory endogenous anterior uveitis, Ophthalmic Res, 39, 184, 10.1159/000103239